Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alex Zukiwski"'
Autor:
Susanne M. Arnold, Tina Runk, Elise Brownell, Robert Cavaliere, Volker W. Stieber, Alex Zukiwski, Jeffrey Raizer, Stefan Proniuk, Randy L. Jensen, Priya Kumthekar, James Vredenburgh, Craig Devoe, Jai Grewal
Publikováno v:
Neuro Oncol
BACKGROUND AR-67 (formerly DB-67) is a novel 3rd generation camptothecin with improved safety and lipophilicity than current drugs in this class. Safety and efficacy of AR-67 were evaluated in a Phase 2 study in recurrent GBM/gliosarcoma in adult pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8724bbc7d4be0f38e6409080e59057f9
https://europepmc.org/articles/PMC6847938/
https://europepmc.org/articles/PMC6847938/
Autor:
Erard M. Gilles, Caroline Denot, Haydee L. Ramos, Alice Bexon, François Lokiec, Keyvan Rezai, Didier Chassard, Stefan Proniuk, Alex Zukiwski
Publikováno v:
Cancer Research. 74:4636-4636
Introduction: Onapristone is an antiprogestin with demonstrated clinical activity in breast cancer, reported to have a t1/2 between 2 and 4 hours. Drugs such as megestrol acetate and abiraterone generally show variability in absorption and, depending
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bb550ad7f038254c2e8eb4798afaa74
https://doi.org/10.1158/1538-7445.am2014-4636
https://doi.org/10.1158/1538-7445.am2014-4636
Publikováno v:
Cancer chemotherapy and pharmacology. 35(6)
To determine the maximum tolerated dose (MTD) of escalating doses of interferon-alpha-2b (IFN, Intron A) with 5-fluorouracil (5-FU) and cisplatin (DDP) in patients with advanced cancer, 15 patients were accrued between May 1990 and July 1991. Primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03a67298c2ef1c59255ceb99b828f726
https://pubmed.ncbi.nlm.nih.gov/7882458
https://pubmed.ncbi.nlm.nih.gov/7882458
Publikováno v:
Acta oncologica (Stockholm, Sweden). 32(5)
On the basis of preclinical data showing synergy between 5-fluorouracil (5-FU), leucovorin (LV) and IFN-alpha-2a, a phase I study was carried out to determine the maximum tolerable dose (MTD) of IFN-alpha-2a with this combination in patients with gas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8833dc0fa38d4590cefedf187d982c9b
https://pubmed.ncbi.nlm.nih.gov/8217238
https://pubmed.ncbi.nlm.nih.gov/8217238
Publikováno v:
American journal of infection control. 16(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9490d72918ca1927db3a189e3d36577
https://pubmed.ncbi.nlm.nih.gov/3144922
https://pubmed.ncbi.nlm.nih.gov/3144922